Experience

• 

  Johnson & johnson

  Jan 1988 - Jan 1989

  Hospital sales representative

  - Introduced the key products in the most relevant hospitals of my area of responsibility.

• 

  Essex pharma gmbh

  Jan 1989 - Jan 1990

  Onco-haematology sales representative

  -Annual sales objective exceeded.

• 

  Schering-plough research institute

  Jan 1990 - Mar 2008

  - Responsible of different oncology drugs for several type of tumors (melanoma, ovarian, head and neck, brain tumors). Achieved a growth of 67%.-To build and deliver strategic and operational plan. -To identify key influencers and maintain relationships with KOL and key professionals. Designed an institutional project to improve the Oncology Business Unit image into the oncology specialty.- Deliver a quality event programs with Spanish Society of Medical Oncology (SEOM).- Developed a Vademecum of Oncology drugs (Oncomecum) sponsored by SEOM. Show less - Launched the first monoclonal antibody anti-TNF(infliximab) in Spain for Immunology diseases. Today is one of the top-selling products in the hospital market and the number 1 in MSD. (169 million euros MAT Nov 14).-Demonstrate entrepreneurial "out of the box" implementing new ideas to grow the assigned products portfolio.- Lead by example, generating support and develop of a group of marketing people. To set up objectives, priorities, development plans and follow up projects and programs with them.- Created support programas for patient associations of hepatitis, transplantation, HIV, Crohn disease and ulcerative colitis and rheumatic diseases.- Expert of organizing educational programs, early diagnostic campaigns and treatment adherence programs to identify new patients and to ensure adherence to treatments. Show less -Give medical input and share recent scientific knowledge (e.g. data on portfolio), being the product internal expert. -Development of the medical strategy.-Active preparation and participation in AB, investigator, and KOLs meetings.-Preparation and presentation of product data in medical congressesl-Deal to customer enquiries and providing medical support.-Lead scientific exchange with customers.-Sales force training in medical topics as requested by the training department.-Permanent scientific and market knowledge update to identify new unmet medical needs and business opportunities.-Designed and initiated local clinical trials to meet scientific needs. Provided medical inputs to develop the medical plan.-Delivered medical training to sales force teams to explain scientific data and brand benefits.-Contributed to the development of brand plans and strategies with broad knowledge of products, patient trends and publications. -Identified high added-value medical programs such as Continuous Medical Educational Programs -Contributed to develop scientific publications-Promotional materials support and review-Prepared and conducted Advisory Boards and Speaker Training Programs Show less

  • Oncology Brand Manager

    Mar 2003 - Mar 2008

  • Marketing Manager in Inflammation & Immunology / Hepatitis / HIV

    Jan 1998 - Mar 2003

  • Hepatitis Franchise Manager

    Jan 1996 - Jan 1998

  • Product Manager

    Jan 1995 - Jan 1996

  • Medical Advisor

    Jan 1990 - Jan 1995
• 

  Merck (msd)

  Mar 2008 - Oct 2014

  Marketing manager and european center of excellence lead

  -To build strategic and operational plans which optimize profitability market share and revenue growth for the assigned rpoducts portfolio.-Effectively allocate marketing Budget to maximize ROI and results.-Full undertanding and use of key market research approaches, giving recommendations and acting on results.-To translate market intelligence into brand/disease strategies and programs.-Active member of the European Brand Team, and leader of the Local Brand Team.-Introduced in the Spanish market the molecule sugammadex, first in its therapeuthical class. Currently Sugammadex in Spain is the worldwide leader in sales. 6 months after the launch the product was available in 70% of Spanish hospitals. Show less

• 

  Qilu pharma spain

  Jul 2015 - Sept 2017

  Business development & regulatory affairs

  -Establishment of the European subsidiary of Qilu Pharmaceutical, for import and marketing generic medicines from its headquarters in China, according to current European regulations.- Product portfolio analysis of pharmaceutical products of Qilu Pharmaceutical to establish the business development strategy at the European market. -To track Regulatory activities and set up the Pharmacovigilance system.-To build the Quality Control System and the Standard Operating Procedures.-Plan Audits and Quality Agreements of outsourced activities.-To prepare theTechnical Report to apply as Marketing Authorisation Holder Show less

• 

  Mabxience

  Sept 2017 - Feb 2019

  Global scientific communication manager

  Training activities at international level on biosimilar medicines (courses, lectures, training materials, e learning programs) for physicians, health authorities, pharmacists, partners and internal employees.

• 

  Stada

  Mar 2019 - now

  Hospital medical manager specialties unit (hospitals & biosimilars) at stada